- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 3 | 4.093 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS00941Q2030 AIRNET... ► Artikel lesen | |
| 03.01. | BIMI International Medical Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.12.23 | BIMI International Medical reports Q3 results | 4 | Seeking Alpha | ||
| 19.12.23 | BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results | 209 | GlobeNewswire (Europe) | NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months and nine... ► Artikel lesen | |
| 19.12.23 | BIMI International Medical Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.12.23 | BIMI International Medical Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 04.12.23 | BIMI International Medical Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.11.23 | BIMI International Medical Inc.: BIMI Announces Buyback of Warrants | 2 | GlobeNewswire (USA) | ||
| 27.11.23 | BIMI International Medical Inc.: BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c) | 175 | GlobeNewswire (Europe) | NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company") today announced that on November 21, 2023, the Company received a notification letter from The Nasdaq Stock... ► Artikel lesen | |
| 27.11.23 | BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results | 170 | GlobeNewswire (Europe) | NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months ended... ► Artikel lesen | |
| 27.11.23 | BIMI International Medical Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.11.23 | BIMI International Medical Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.11.23 | BIMI International Medical Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 08.11.23 | BIMI International Medical Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 08.11.23 | BIMI International Medical Inc.: BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch | 1 | GlobeNewswire (USA) | ||
| 30.10.23 | BIMI International Medical Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.10.23 | BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor | 2 | GlobeNewswire (USA) | ||
| 30.10.23 | BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor | 1 | GlobeNewswire (USA) | ||
| 24.08.23 | BIMI International Medical Inc.: BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c) | 304 | GlobeNewswire (Europe) | NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company") today announced that on August 22, 2023, the Company received a notification letter from The Nasdaq Stock... ► Artikel lesen | |
| 07.08.23 | BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group | 336 | GlobeNewswire (Europe) | NEW YORK, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a leading global provider of healthcare services and innovative medical solutions, today announced... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 26,450 | -0,75 % | Fresenius - geht da was? | Der DAX-Konzern Fresenius will sich neu organisieren und hat deshalb - nach fast 30 Jahren Zusammenarbeit - die Fresenius Medical Care (FMC) dekonsolidiert?. Zusätzlich hat der Gesundheitskonzern für... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 35,930 | -1,37 % | FMC-Aktie mit Kursverlusten (55,0585 €) | Im Minus liegt zur Stunde der Anteilsschein von FMC . Das Papier kostete zuletzt 58,59 US-Dollar. Eine Verbilligung in Höhe von 2,95 US-Dollar müssen derzeit die Aktionäre von FMC hinnehmen. Gegenwärtig... ► Artikel lesen | |
| GERRESHEIMER | 98,45 | -1,55 % | Gerresheimer: Gute Zahlen, schwache Aktie … was ist da los? | Der Verpackungsmittelspezialist Gerresheimer legte am Donnerstag die Ergebnisse für das erste Quartal vor, die vielleicht nicht hervorragend, aber doch leicht über den Prognosen ausfielen. Die Aktie... ► Artikel lesen | |
| UNITEDHEALTH | 460,95 | -0,54 % | UnitedHealth Aktie: Quartalszahlen über Prognosen hinaus | UnitedHealth Group, der größte US-Krankenversicherer, hat im ersten Quartal 2024 überraschend positive Geschäftszahlen vorgelegt. Mit einem Gewinn pro Aktie von 6,91 US-Dollar wurden die Schätzungen... ► Artikel lesen | |
| STRATEC | 40,050 | 0,00 % | WARBURG RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Stratec vor Zahlen von 54 auf 47 Euro gesenkt, aber die Einstufung auf "Hold" belassen. Das erste Quartal dürfte für... ► Artikel lesen | |
| BIOTEST | 28,700 | 0,00 % | EQS-News: Biotest AG eröffnet 12. Plasmasammelzentrum in Deutschland | EQS-News: Biotest AG
/ Schlagwort(e): Sonstiges
Biotest AG eröffnet 12. Plasmasammelzentrum in Deutschland
19.04.2024 / 09:00 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| PLUS THERAPEUTICS | 1,536 | -5,30 % | Plus Therapeutics Inc.: Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus' Management Team | The addition of both Dr. Brenner and Dr. Blouw substantially expands Plus internal expertise in key areas Dr. Brenner will maintain his academic commitments but will greatly contribute to Plus' scientific... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,290 | -3,01 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 20,220 | 0,00 % | Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange | SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 51,08 | 0,00 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 31,880 | -2,66 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
| ADAPTHEALTH | 9,360 | -0,74 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | ||
| EUROPEAN WAX CENTER | 11,300 | +4,05 % | European Wax Center, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results | Fiscal Year 2023 versus 2022 Net new centers increased 10.6% to 1,044 total centers in 45 statesSystem-wide sales of $955.0 million increased 6.3%Total revenue of $221.0 million increased 6.6%Same-store... ► Artikel lesen | |
| NANO-X IMAGING | 9,070 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen |
BIMI INTERNATIONAL MEDICAL INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,280 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
